Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 11, 2014Cellular and Molecular Life SciencesOpen Access

Longevity, aging and rapamycin

View Full Paper
Ask AI
Bookmark
Share

Authors

DEDan EhningerGerman Center for Neurodegenerative DiseasesFNFrauke NeffMünchen Klinik NeuperlachKXKan XieGerman Center for Neurodegenerative Diseases

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ehninger et al. (2014) studied this question.

synapsesocial.com/papers/69d9abcfa1d151c65f684d1bhttps://doi.org/10.1007/s00018-014-1677-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition2006 · 384 citations
  2. 2Hazzard’s Geriatric Medicine and Gerontology2009 · 524 citations
  3. 3Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver2013 · 64 citations